Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Agilent Completes Varian Acquisition
by Marc S. Reisch
May 24, 2010
| A version of this story appeared in
Volume 88, Issue 21
Following Federal Trade Commission approval, Agilent has completed its $1.5 billion acquisition of fellow instrument maker Varian, advancing its strategy to become a leader in bioanalytical instrumentation. Completion of the deal, struck in July 2009, was delayed as the two awaited government clearances. To satisfy European regulators, Agilent earlier agreed to sell its micro gas chromatography business to Switzerland’s Inficon and three Varian businesses to Bruker (C&EN, March 15, page 28).
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X